| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.371.904 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.749 | 1.375.518 |
| Total Expenses - EUR | 29 | 1.114 | 209 | 42 | 107 | 0 | 0 | 0 | 265.977 | 1.228.434 |
| Gross Profit/Loss - EUR | -29 | -1.114 | -209 | -42 | -107 | 0 | 0 | 0 | -256.228 | 147.084 |
| Net Profit/Loss - EUR | -29 | -1.114 | -209 | -42 | -107 | 0 | 0 | 0 | -256.228 | 139.736 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 18 |
Check the financial reports for the company - Arensia Clinics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 88 | 92 | 0 | 49 | 0 | 0 | 0 | 0 | 454.183 | 420.668 |
| Current Assets | 198 | 81 | 65 | 64 | 42 | 41 | 40 | 41 | 59.929 | 170.131 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.512 | 95.362 |
| Cash | 198 | 81 | 65 | 64 | 42 | 41 | 40 | 41 | 50.417 | 74.768 |
| Shareholders Funds | 16 | -1.098 | -1.288 | -1.307 | -1.388 | -1.362 | -1.332 | -1.336 | -257.560 | -116.384 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 270 | 1.271 | 1.353 | 1.420 | 1.430 | 1.403 | 1.372 | 1.376 | 771.750 | 707.254 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Arensia Clinics S.r.l.